Biotech | March 07, 2022
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals form CDMO
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport
Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem
Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
Subscribe To Our Newsletter & Stay Updated
